Drugs in R&D was re-launched in 2010 as the first Open Access journal from Adis.
The journal publishes original research and reviews on drugs from all phases of drug development and clinical use following approval.
Manuscripts submitted to the journal for publication will be subject to a $3,000/€2,200 (excluding VAT) article processing charge (APC) upon acceptance. Adis Open Access enables you to make your journal article freely available to anyone, in exchange for payment of APC. This option allows you, the author, to retain the copyright of the article according to the terms of the Creative Commons Attribution Non-Commercial (CC BY-NC) License, which does not permit commercial re-use of the article.
PubMed/Medline, SCOPUS, EMBASE, Chemical Abstracts Service (CAS), Google Scholar, EBSCO, Academic OneFile, Academic Search, CSA Environmental Sciences, Expanded Academic, Health Reference Center Academic, Journals@OVID, OCLC, SCImago, Summon by ProQuest